Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Pyxis Oncology Inc. (PYXS)
-
-
-
-
-
-
-
Why Jefferies sees these stocks as standout biotech plays in 2026
-
-
-
-
-
-
-
Guggenheim Starts Pyxis Oncology Inc. (PYXS) at Buy
-
-
-
-
-
-
-
Pyxis Oncology (PYXS) Initiates New PYX-201 Combination Trial
-
-
-
-
-
-
-
Pyxis Oncology (PYXS) call put ratio 1.3 calls to 1 put into investor event
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Pyxis Oncology Inc. (PYXS)
-
428,420 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

